Tulåh Clinical Wellness in Kozhikode, Kerala, has partnered with US-based medical second-opinion platform Apex Opinion. The collaboration will give Indian patients access to independent assessments from US board-certified specialists without travelling overseas. The service is expected to launch in November 2026, subject to operational readiness.
The two parties signed a Memorandum of Understanding in Boston on 30 October 2026. Faizal E. Kottikollon, Founder and Chairman of KEF Holdings and Tulåh Clinical Wellness, signed on behalf of Tulåh. Saurabh Sanon, Founder and CEO of Krivox Inc., which operates Apex Opinion, represented the US platform.
The partnership supports Tulåh's vision of combining modern medicine with traditional healing practices. It will initially cover complex medical conditions across several specialties, including cardiology, oncology and neurology.
Patients will be able to submit their medical records for review by US specialists. They can expect to receive expert opinions within seven business days. The service may also offer video consultations with specialists.
"Our collaboration with Apex Opinion is another step towards making global medical expertise accessible to people in India," said Kottikollon.
Sanon added: "We hope to make expert US medical opinions more accessible to patients in India, whilst ensuring that their ongoing care remains with their own treating physicians."
The partnership aims to give patients greater confidence in their diagnoses and treatment options. It will also allow them to access international medical expertise while continuing their care with local physicians.
This story was selected and published by a human editor, with content adapted from original press material using AI tools. Spot an error? Report it here.
